M
Medly AI
Personalised AI tutor for student exam preparation.
About Medly AI
Medly AI is a London edtech company founded in 2023 by former NHS doctors and UCL medicine graduates Dr. Paul Jung (CEO) and Dr. Kavi Samra that builds a curriculum-aligned AI tutor for exam preparation. Aimed at students aged roughly 14–18 (GCSEs, IGCSEs, A-Levels, IB, with US SAT/AP expansion), the platform combines multiple specialised models with neuroscience-informed teaching, instant marking and feedback, handwriting recognition and progress tracking so learners get personalised tutoring without premium private-tutor prices. Since launching in February 2025 Medly reports rapid UK growth (hundreds of thousands of users) and grade-improvement outcomes in exam seasons; it also offers Medly Open for university students. After a February 2025 £1.7 million round led by Eka Ventures with Ada Ventures, Medly raised a €6.89 million ($8 million) Seed in August 2026 led by Felix Capital with Eka, Ada and angels, to grow the UK community, expand internationally and deepen proprietary marking and pedagogy models; it also won a UK Department for Education AI Tutoring Tools Pioneers grant. Sources: EU-Startups 19 Aug 2026.
Source: Dealroom company dataAt a glance
- Founded
- 2023
- Headquarters
- London, United Kingdom
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
Eka Ventures
Ada Ventures
Felix Capital
Jean Hammond
Creator Fund
Al Giles
Episode 1 Ventures
Hector Mason
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medly AI on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medly AI on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.